Clinical Trials in Houston

Showing 6021-6040 of 13,620 trials

Use of Wearable Digital Sensors After mRNA Vaccination in Adults

NCT05440318

The purpose of this study is to explore the physiological and behavioral impact of the immune response to vaccines after receipt of investigational or approved messenger ribonucleic acid (mRNA) vaccines using wearable medical sensors, with the potential of establishing a digital biomarker of vaccine response due to stimulation of the immune system.

Healthy Participants

ModernaTX, Inc.62 participantsStarted Jun 2022

Lenexa, Kansas, United States • Lincoln, Nebraska, United States • Austin, Texas, United States +1 more locations

TERMINATEDPhase 1< 1 mile

Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study

NCT03523767

The purpose of this pilot study is to investigate and compare the effect of a mild inflammatory stimulus (typhoid vaccine) on immune response, mood and cognition in healthy volunteers compared to patients with history Major Depressive Disorder (MDD) (not currently depressed and no symptoms of depression in the past 6 months).

Major Depressive Disorder

The University of Texas Health Science Center, Houston19 participantsStarted Feb 2018

Houston, Texas, United States

COMPLETEDPhase 2/3< 1 mile

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

NCT00442533

The purpose of this study is to determine if High-dose 111In-Pentetreotide known as NeuroendoMedix®, is an effective treatment for Neuroendocrine Tumors.

Neuroendocrine Tumors

Radio Isotope Therapy of America200 participantsStarted Aug 2005

Houston, Texas, United States • Houston, Texas, United States

Use of Wearable Digital Sensors After mRNA Vaccination in Adults

Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

Find Trials by Condition in Houston

Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work

HR-EGG in Medically Refractory Gastroparesis

S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175